Search

Milan Bunata, MB Pharma Hi everyone, has your phage activities been affected by the COVID situation? If so, how? Fortunately, we are still 100% working, but not knowing if we are the only one? Or one of few? What is your situation? bunata@m

Can phages help COVID patients? We've been hearing chatter about this subject from the phage community over the last few days, so we've decided to start the conversation here and keep it going. What, if anything, can the phage community do

Adair Borges and colleagues from the Bondy-Denomy lab at UCSF have published a paper discussing how Pseudomonas aeruginosa host factors, previously characterized for their role in alginate biosynthesis, affect its Type I-F CRISPR–Cas system

A PhD position investigating phage immunogenicity is available at the Institute of Virology, University of Bonn Medical School, Germany. The PhD studentship, under the supervision of Prof. Dr. med. Hendrik Streeck, will explore the potentia

Adaptive Phage Therapeutics (APT), having recently doubled its biologics manufacturing capability (intended for its upcoming phage clinical trials), is currently in talks with a partner to help with rapid production of a COVID-19 vaccine ca

A 3-year position as an Assistant Professor working on the characterization of phages and determining the mechanisms of host recognition and resistance development is open at the University of Copenhagen, Denmark.

Michelle Bach (Stanford University) and colleagues published a new preprint on how the filamentous phage Pf (present in 69% of Pseudomonas aeruginosa wounds) delays healing of P. aeruginosa-infected wounds by provoking an anti-phage immune

Gabriel Magno de Freitas Almeida and Lotta-Riina Sundberg (University of Jyvaskyla, Finland) have published a historical review in The Lancet Infectious Diseases that dives into the forgotten history of phage therapy in Brazil. They show th

Lawrence Berkeley National Lab's Environmental Genomics & Systems Biology Division has an opening for a postdoc position that will develop and apply mass spectrometry-based metabolomic analysis methods to understand viral reprogramming of m

A postdoc position focusing on studying the role of phages in the gut microbiota and engineering them for therapeutic function is available in the lab of Dr. Bryan Hsu at Virginia Tech (Blacksburg, VA).

A PhD position investigating phage immunogenicity is available at the Institute of Virology, University of Bonn Medical School, Germany. The PhD studentship, under the supervision of Prof. Dr. med. Hendrik Streeck, will explore the potentia

A Senior Associate Scientist position is open with Pfizer working on the isolation and optimization of antibodies using phage display.

A 3-year position as an Assistant Professor working on the characterization of phages and determining the mechanisms of host recognition and resistance development is open at the University of Copenhagen, Denmark.

Phage Directory has three new volunteers! Please welcome Lauren Dunlop, Dr. Rohit Kongari and Lizzie Richardson! Lauren helps us behind the scenes with things like finding out about grants we can apply for. Rohit and Lizzie are currently he

On account of the current situation of worldwide spreading coronavirus SARS-CoV2, the organising committee might have to consider post-postponing Viruses of Microbes 2020, initially planned to take place on the 13-17 July. However, due to t

From Karen Maxwell, via Twitter: #phage community - which phage is most SARS-CoV2 like? Seems like many assays for inactivation, etc could be widely performed and then translated. Who has stocks???

From Elizabeth McDaniel, via Twitter: There’s a lot of interest right now for learning bioinformatics skills while lab research is suspended and everybody is working from home. I wanted to share free resources for learning coding basics and

Adaptive Phage Therapeutics (APT), having recently doubled its biologics manufacturing capability (intended for its upcoming phage clinical trials), is currently in talks with a partner to help with rapid production of a COVID-19 vaccine ca

Ella Balasa, one of our guest writers and volunteers, and former phage therapy recipient, has written about what it's like being at high risk for COVID-19; a very sobering read (though it ends on a positive note!).

Gabriel Magno de Freitas Almeida and Lotta-Riina Sundberg (University of Jyvaskyla, Finland) have published a historical review in The Lancet Infectious Diseases that dives into the forgotten history of phage therapy in Brazil. They show th